Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17658595 | 0.89 | ALOX5 (0.37) | ALOX5HDAC8 | |
| SCHEMBL14295291 | 0.85 | ALOX5 (0.40) | ALOX5LMNAMAPTNPC1MAOA | |
| SCHEMBL26815441 | 0.84 | ALOX5 (0.47) | ALOX5LMNAHDAC8 | |
| SCHEMBL15730662 | 0.84 | ALOX5 (0.39) | ALOX5LMNAMAPTNPC1MAOA | |
| SCHEMBL15306316 | 0.84 | ALOX5 (0.41) | ALOX5LMNAMAPTNPC1MAOA | |
| SCHEMBL17716679 | 0.81 | ALOX5 (0.42) | ALOX5LMNAMAPTNPC1MAOA | |
| SCHEMBL6372493 | 0.81 | ALOX5 (0.42) | ALOX5LMNAMAPTNPC1MAOA | |
| SCHEMBL14295254 | 0.81 | ALOX5 (0.42) | ALOX5LMNAMAPTNPC1MAOA | |
| SCHEMBL15178580 | 0.81 | ALOX5 (0.41) | ALOX5LMNAMAPTNPC1MAOA | |
| SCHEMBL29294345 | 0.81 | CNR2 (0.32) | LMNANPC1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9923147-B2 | Organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-20 | — | — | US | disclosed |
| US-9856243-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-02 | — | — | US | disclosed |
| US-20160329501-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-11-10 | — | — | US | disclosed |
| US-20160099423-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160099423-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, MCM4 | ALOX5 2708/4885LMNA 1368/4885MAPT 1667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.